Local Delivery of Mometasone Furoate from an Eluting Endotracheal Tube Reduces Airway Morbidity following Long-Term Animal Intubation

Forsan Jahshan, Aiman Abu Ammar, Offir Ertracht, Netanel Eisenbach, Amani Daoud, Eyal Sela, Shaul Atar, Eyal Zussman, Boris Fichtman, Amnon Harel, Maayan Gruber

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Background: upper airway complications are common sequelae of endotracheal tube (ETT) intubation, and systemic corticosteroids are considered a mainstay treatment for this problem. Drug-eluting ETT may present an attractive option for topical steroid delivery while avoiding systemic side effects and improving the therapeutic outcome. The objective of the present study is to evaluate the reduction of tube-related tracheal morbidity via a self-designed steroid-eluting ETT with controlled sustained release properties in an animal model. Methods: steroid-eluting ETTs were coated by poly(lactic-co-glycolic acid) -electrospun nanofibers loaded with mometasone furoate (MF) as a model drug. Animals were randomly assigned into three equal groups: non-intubated, blank-ETT, and loaded-ETT. The intubation interval was 1 week. Specimens were analyzed by histology, specific fibrosis staining, and scanning electron microscopy (SEM). Results: the blank-ETT group exhibited a significant increase in tracheal mucosal thickness compared to the loaded-ETT and control groups. Average tracheal mucosal thickness was 112 ± 34, 242 ± 49, and 113 ± 43 μm in the control, blank-ETT, and loaded-ETT groups, respectively. The blank-ETT group exhibited a significant increase in tracheal fibrosis compared to the loaded-ETT and control groups. Relative fibrosis values were 0.07 ± 0.05, 0.154 ± 0.1, and 0.0984 ± 0.084% for the control, blank-ETT, and loaded-ETT groups, respectively. While SEM imaging showed normal surface structures in the control group, intubated blank-ETT rats showed severe surface structural damage, whereas only mild damage was observed in the loaded-ETT group. Conclusions: local sustained release of MF via a self-designed drug-eluting ETT is a potential therapeutic approach which may significantly reduce tube-related upper airway morbidity.

Original languageEnglish
Pages (from-to)4131-4139
Number of pages9
JournalACS Applied Bio Materials
Volume4
Issue number5
DOIs
StatePublished - 17 May 2021

Bibliographical note

Publisher Copyright:
© 2021 American Chemical Society.

Keywords

  • animal
  • endotracheal tube
  • nanotechnology
  • steroid
  • trachea

Fingerprint

Dive into the research topics of 'Local Delivery of Mometasone Furoate from an Eluting Endotracheal Tube Reduces Airway Morbidity following Long-Term Animal Intubation'. Together they form a unique fingerprint.

Cite this